Supporting the future discovery of new medicines in the UK

21 May 2010

The global pharmaceutical sector is in a period of significant transition. Mergers of large pharmaceutical companies in recent years have produced global giants. However, there is a feeling that the 'big' pharmaceutical model is broken as the search for new products has become ever more, possibly prohibitively, expensive and is no more reliable. 

In addition, governments across the world are striving to contain healthcare costs by exerting downward pressures on pricing, whilst opportunities for growth are opening up as new markets develop - especially in Asia where economic growth is raising standards of living and expectations of improved health care.

In response to this, the Royal Society of Chemistry has released a position statement detailing the current situation in the pharmaceutical industry and proposing measures that will ensure a strong future for this important sector.